We conclude from our study that a combinatorial regimen of anti‐EGFL7 together with the angiogenesis inhibitor anti‐VEGF and the chemotherapeutic agent temozolomide may serve as a novel treatment option for patients suffering from malignant glioma. The gene discussed is VEGFA; the disease is malignant glioma.